FT538

· Fate Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FT538, covering 2024-10-24 to 2025-08-14. Get the full timeline:

Most recent: Clinical Trial Update: MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]